Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation

International Immunopharmacology

Volumn 10, Issue 8, 2010, Pages 922-928

  Bartels, Lars E ^a,b   Hvas, Christian L ^b   Agnholt, Jørgen ^b   Dahlerup, Jens F ^b   Agger, Ralf ^a  

^a AALBORG UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

1 alpha hydroxylase; 25 hydroxy vitamin D3; Chemotaxis; Cholecalciferol; Dendritic cells

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 1,25 DIHYDROXYERGOCALCIFEROL VITAMIN D3; B7 ANTIGEN; BIOLOGICAL MARKER; CD14 ANTIGEN; CD83 ANTIGEN; CHEMOKINE; CHEMOKINE LIGAND 21; CYTOKINE; HLA DR ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TETANUS TOXOID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADULT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROXYLATION; IMMUNOMODULATION; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MONOCYTE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; T LYMPHOCYTE; TETANUS PROPHYLAXIS;

ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; CELL DIFFERENTIATION; CELLS, CULTURED; CHEMOKINE CCL21; CHEMOTAXIS; CHOLECALCIFEROL; CYTOCHROME P-450 CYP27A1; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNOMODULATION; LIPOPOLYSACCHARIDES; MONOCYTES;

EID: 77954956449     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.05.003     Document Type: Article

References (33)

1. Autier P., Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167:1730-1737.
2. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
3. Jones G., Strugnell S.A., DeLuca H.F. Current understanding of the molecular actions of vitamin. D Physiol Rev 1998, 78:1193-1231.
4. Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000, 374:334-338.
5. Kubach J., Becker C., Schmitt E., Steinbrink K., Huter E., Tuettenberg A., et al. Dendritic cells: sentinels of immunity and tolerance. Int J Hematol 2005, 81:197-203.
6. van Halteren A.G., Tysma O.M., van Etten E., Mathieu C., Roep B.O. 1alpha, 25-Dihydroxyvitamin D(3) or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 2004, 23:233-239.
7. Penna G., Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000, 164:2405-2411.
8. Pedersen A.E., Gad M., Walter M.R., Claesson M.H. Induction of regulatory dendritic cells by dexamethasone and 1alpha, 25-Dihydroxyvitamin D(3). Immunol Lett 2004, 91:63-69.
9. Canning M.O., Grotenhuis K., de Wit H., Ruwhof C., Drexhage H.A. 1-alpha, 25-Dihydroxyvitamin D3 (1, 25(OH)(2)D(3)) hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 2001, 145:351-357.
10. Ureta G., Osorio F., Morales J., Rosemblatt M., Bono M.R., Fierro J.A. Generation of dendritic cells with regulatory properties. Transplant Proc 2007, 39:633-637.
11. Penna G., Roncari A., Amuchastegui S., Daniel K.C., Berti E., Colonna M., et al. Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1, 25-dihydroxyvitamin D3. Blood 2005, 106:3490-3497.
12. Willheim M., Thien R., Schrattbauer K., Bajna E., Holub M., Gruber R., et al. Regulatory effects of 1alpha, 25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J Clin Endocrinol Metab 1999, 84:3739-3744.
13. Bartels L.E., Jorgensen S.P., Agnholt J., Kelsen J., Hvas C.L., Dahlerup J.F. 1, 25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease. Int Immunopharmacol 2007, 7:1755-1764.
14. Penna G., Amuchastegui S., Giarratana N., Daniel K.C., Vulcano M., Sozzani S., et al. 1, 25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 2007, 178:145-153.
15. Enioutina E.Y., Bareyan D., Daynes R.A. Vitamin D3-mediated alterations to myeloid dendritic cell trafficking in vivo expand the scope of their antigen presenting properties. Vaccine 2007, 25:1236-1249.
16. Fujita H., Asahina A., Komine M., Tamaki K. The direct action of 1alpha, 25(OH)2-vitamin D3 on purified mouse Langerhans cells. Cell Immunol 2007, 245:70-79.
17. Hathcock J.N., Shao A., Vieth R., Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007, 85:6-18.
18. Fritsche J., Mondal K., Ehrnsperger A., Andreesen R., Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003, 102:3314-3316.
19. Hewison M., Burke F., Evans K.N., Lammas D.A., Sansom D.M., Liu P., et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007, 103:316-321.
20. Fraser W.D., Durham B.H., Berry J.L., Mawer E.B. Measurement of plasma 1, 25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann Clin Biochem 1997, 34(Pt 6):632-637.
21. Hewison M., Freeman L., Hughes S.V., Evans K.N., Bland R., Eliopoulos A.G., et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003, 170:5382-5390.
22. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 2008, 214:149-160.
23. Berer A., Stockl J., Majdic O., Wagner T., Kollars M., Lechner K., et al. 1, 25-Dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000, 28:575-583.
24. Enioutina E.Y., Bareyan D., Daynes R.A. TLR ligands that stimulate the metabolism of vitamin D3 in activated murine dendritic cells can function as effective mucosal adjuvants to subcutaneously administered vaccines. Vaccine 2008, 26:601-613.
25. Tang J., Zhou R., Luger D., Zhu W., Silver P.B., Grajewski R.S., et al. Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 2009, 182:4624-4632.
26. Jones G.W., McLoughlin R.M., Hammond V.J., Parker C.R., Williams J.D., Malhotra R., et al. Loss of CD4+ T Cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol 2010, 184:2130-2139.
27. Sellge G., Magalhaes J.G., Konradt C., Fritz J.H., Salgado-Pabon W., Eberl G., et al. Th17 cells are the dominant T Cell subtype primed by shigella flexneri mediating protective immunity. J Immunol 2010, 184:2076-2085.
28. Pasare C., Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
29. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
30. Szeles L., Keresztes G., Torocsik D., Balajthy Z., Krenacs L., Poliska S., et al. 1, 25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 2009, 182:2074-2083.
31. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., et al. Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004, 173:2909-2912.
32. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol 2007, 179:2060-2063.
33. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.